Results 191 to 200 of about 189,934 (383)

Haemoglobin for Fall Risk Screening in Gynaecological and Obstetric Wards: Retrospective Survey and Delphi Validation

open access: yesNursing Open
Aims The objective of this study is to ascertain the suitability of haemoglobin as a screening factor for falls among obstetrics and gynaecology inpatients and to formulate a stratified scheme for assessing fall risk based on haemoglobin.
Bijun Mao   +8 more
doaj   +1 more source

Mental health amongst obstetrics and gynaecology doctors during the COVID-19 pandemic: Results of a UK-wide study

open access: yesEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology, 2020
N. Shah   +4 more
semanticscholar   +1 more source

Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Preeclampsia is protective against breast cancer, but it is not clear if the effect extends to all breast tumors. This study examined the association between preeclampsia and breast tumor histology. The findings suggest that the protective effect of preeclampsia is concentrated among ductal and lobular tumors, but not other tumors. Patients
Shu Qin Wei   +8 more
wiley   +1 more source

Cost-effective safe motherhood interventions in low-income countries: a review [PDF]

open access: yes
This paper reviews studies providing evidence of the cost-effectiveness of safe motherhood interventions in low-income countries. The economic case for investing in safe motherhood interventions is also examined.
Matthew Jowett
core  

True Double Umbilical Cord Knots with Good Fetal Outcome: An Incidental Finding on Delivery

open access: yesInternational Medical Case Reports Journal
Leonard Ssebwami,1,2 Koros Aron Kiptoo,2 Joan Diana Nabirye,1 Immaculate Ayebare,1 Simon Byonanuwe2 1Department of Obstetrics and Gynaecology, Hoima Regional Referral Hospital, Hoima, Uganda; 2Department of Obstetrics and Gynaecology, Kampala ...
Ssebwami L   +4 more
doaj  

Invasive disease‐free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor‐positive, HER2‐negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Neoadjuvant chemotherapy (NACT) can be highly effective for patients with early‐stage breast cancer. Patients with hormone receptor‐positive (HRpos), HER2‐negative (HER2neg) breast cancer, however, may benefit less from NACT. Here, the authors investigated survival outcomes with adjuvant chemotherapy or NACT in a population of ...
Milena Beierlein   +43 more
wiley   +1 more source

Home - About - Disclaimer - Privacy